Human Mixtard 30/70 Injection 100 Iu/ml Vial 10 ml

Helps to improve blood sugar levels in diabetic patients

Every medication contains unwanted side effects. Human mixtard 30/70 Injection 100 lU/ML also causes symptoms that are unseen on early diagnosis, but slowly it can lead to issues. If you experience any of these symptoms, kindly consult a healthcare professional to avoid complications during the treatment. Common ones include:

• Low blood sugar (Hypoglycaemia)
• Lightheadedness
• Dizziness
• Anxiety
• Nervousness
• Tiredness
• Feeling hungry
• Visual disturbances
• Headache
• Shaking
• Sweating
• Pale skin
• Skin rashes
• Pain, redness, swelling at the injection site.

Human mixtard 30/70 Injection 100 lU/ML should be taken twice a day, before or after taking a meal, adjusting it according to the blood sugar level and diet. The medication is injected in the upper arm, thigh, abdomen, and buttocks; also, rotate the injection site to prevent skin problems such as lipodystrophy. Never skip or overdose on the medication without consultation with a healthcare professional to ensure safe and effective treatment.

Human Mixtard 30/70 Injection 100 lU/ML contains two active drugs, both forms of insulin, which are needed to help the body regulate blood sugar by promoting the uptake of glucose into the cells, inhibiting glucose production by the liver, and maintaining normal blood glucose levels throughout the day. It belongs to the group of anti diabetic agents and is classified as a hormone replacement therapy for managing low blood sugar levels in the body.

• Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A. (2002). Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients. Diabetic Medicine, 19(5), 393-399. https://pubmed.ncbi.nlm.nih.gov/12027927/
• Mattoo, V., Milicevic, Z., Malone, J. K., Schwarzenhofer, M., Ekangaki, A., Levitt, L. K., ... & Ramadan Study Group. (2003). A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes research and clinical practice, 59(2), 137-143. https://pubmed.ncbi.nlm.nih.gov/12560163/
• Pørksen, N., Nyholm, B., Veldhuis, J. D., Butler, P. C., & Schmitz, O. (1997). In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. American Journal of Physiology-Endocrinology and Metabolism, 273(5), E908-E914. https://pubmed.ncbi.nlm.nih.gov/9374676/
• Pickup, J. (1986). Human insulin. British Medical Journal (Clinical research ed.), 292(6514), 155. https://www.bmj.com/content/292/6514/155
• Pickup, J. (1989). Human insulin. BMJ: British Medical Journal, 299(6706), 991. https://pubmed.ncbi.nlm.nih.gov/2511956/